Wang Qi, Ma Li, Zhai Kan, Yi Feng-Shuang, Shi Huan-Zhong, Shao Ming-Ming
Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Clinical Center for Pleural Diseases, Capital Medical University, Beijing, China.
J Thorac Dis. 2025 Apr 30;17(4):2339-2349. doi: 10.21037/jtd-24-1676. Epub 2025 Apr 16.
Accurate diagnosis of tuberculous pleural effusion (TPE) with biomarkers remains difficult. Interleukin 32gamma (IL-32γ) is a recently discovered proinflammatory cytokines which plays a vital role in the immune response to TPE. This study aimed to assess the diagnostic accuracy of IL-32γ for TPE, especially in different ages of patients.
Patients with a confirmed diagnosis of pleural effusion were systematically recruited from Beijing Chao-Yang Hospital between June 2019 and May 2022. The concentration of IL-32γ and interferon-gamma (IFN-γ) were evaluated in the pleural effusions with different etiology from 188 patients using enzyme-linked immunosorbent assay method. Adenosine deaminase (ADA) was determined by peroxidase method.
At a threshold value of 181.56 ng/L, IL-32γ demonstrated an area under the curve (AUC) of 0.812 [95% confidence interval (CI): 0.748-0.865], with sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), positive predictive value (PPV), and negative predictive value (NPV) of 70.2%, 86.0%, 5.0, 0.4, 92.0%, and 55.7%, respectively. In elderly patients (aged >65 years), IL-32γ demonstrated an AUC of 0.984 (95% CI: 0.891-1.000). Notably, the diagnostic accuracy of IL-32γ was significantly higher than that of ADA (P=0.03) and IFN-γ (P=0.02). Similarly, the AUCs for IL-32γ combined with ADA (0.981, 95% CI: 0.886-1.000) and IL-32γ combined with IFN-γ (1.000, 95% CI: 0.920-1.000) were significantly higher than those of ADA (P=0.04) or IFN-γ (P=0.01) alone in elderly patients.
IL-32γ can be used as a valuable biomarker for identifying patients with TPE, especially in elderly patients aged >65 years.
利用生物标志物准确诊断结核性胸腔积液(TPE)仍然困难。白细胞介素32γ(IL-32γ)是最近发现的一种促炎细胞因子,在对TPE的免疫反应中起重要作用。本研究旨在评估IL-32γ对TPE的诊断准确性,尤其是在不同年龄段患者中的准确性。
2019年6月至2022年5月期间,从北京朝阳医院系统招募确诊为胸腔积液的患者。采用酶联免疫吸附测定法评估188例不同病因胸腔积液患者的IL-32γ和干扰素-γ(IFN-γ)浓度。采用过氧化物酶法测定腺苷脱氨酶(ADA)。
在阈值为181.56 ng/L时,IL-32γ的曲线下面积(AUC)为0.812 [95%置信区间(CI):0.748-0.865],敏感性、特异性、阳性似然比(PLR)、阴性似然比(NLR)、阳性预测值(PPV)和阴性预测值(NPV)分别为70.2%、86.0%、5.0、0.4、92.0%和55.7%。在老年患者(年龄>65岁)中,IL-32γ的AUC为0.984(95%CI:0.891-1.000)。值得注意的是,IL-32γ的诊断准确性显著高于ADA(P=0.03)和IFN-γ(P=0.02)。同样,在老年患者中,IL-32γ与ADA联合(0.981,95%CI:0.886-1.000)和IL-32γ与IFN-γ联合(1.000,95%CI:0.920-1.000)的AUC显著高于单独的ADA(P=0.04)或IFN-γ(P=0.01)。
IL-32γ可作为识别TPE患者的有价值生物标志物,尤其是在年龄>65岁的老年患者中。